Analysts Set Delcath Systems, Inc. (NASDAQ:DCTH) Price Target at $22.50

Delcath Systems, Inc. (NASDAQ:DCTH) has been assigned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $22.50.

A number of research firms have weighed in on DCTH. Weiss Ratings restated a “sell (d+)” rating on shares of Delcath Systems in a research report on Monday, December 29th. BTIG Research cut their price objective on Delcath Systems from $23.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Wall Street Zen lowered Delcath Systems from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. HC Wainwright reissued a “buy” rating and set a $30.00 price objective on shares of Delcath Systems in a report on Friday, January 9th. Finally, Evercore set a $27.00 target price on Delcath Systems in a research report on Thursday, February 26th.

Institutional Investors Weigh In On Delcath Systems

A number of hedge funds have recently made changes to their positions in the business. Millennium Management LLC boosted its stake in shares of Delcath Systems by 34.1% in the 1st quarter. Millennium Management LLC now owns 422,066 shares of the company’s stock valued at $5,373,000 after purchasing an additional 107,391 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Delcath Systems by 58.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 123,487 shares of the company’s stock valued at $1,572,000 after purchasing an additional 45,695 shares during the last quarter. Geode Capital Management LLC raised its position in Delcath Systems by 128.1% in the 2nd quarter. Geode Capital Management LLC now owns 703,171 shares of the company’s stock worth $9,565,000 after purchasing an additional 394,902 shares during the period. Police & Firemen s Retirement System of New Jersey purchased a new position in Delcath Systems in the 2nd quarter worth $97,000. Finally, Intech Investment Management LLC bought a new stake in Delcath Systems in the second quarter worth $197,000. 61.12% of the stock is currently owned by institutional investors.

Delcath Systems Price Performance

Shares of NASDAQ:DCTH opened at $8.97 on Friday. The company’s fifty day moving average price is $9.58 and its 200-day moving average price is $9.95. The firm has a market capitalization of $311.71 million, a price-to-earnings ratio of 128.14 and a beta of 0.38. Delcath Systems has a one year low of $8.12 and a one year high of $18.23.

Delcath Systems (NASDAQ:DCTH) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01. Delcath Systems had a net margin of 3.17% and a return on equity of 2.63%. The firm had revenue of $20.73 million for the quarter, compared to analysts’ expectations of $20.35 million. As a group, equities research analysts expect that Delcath Systems will post -0.79 EPS for the current year.

About Delcath Systems

Delcath Systems, Inc is a specialty pharmaceutical and medical technology company focused on the development and commercialization of its proprietary Hepatic CHEMOSAT® Delivery System, designed to deliver high-dose chemotherapeutic agents directly to the liver while minimizing systemic exposure. The company’s core technology performs isolated hepatic perfusion, enabling oncologists to administer concentrated melphalan to patients with primary and metastatic liver tumors, including those arising from ocular melanoma.